TP53 Mutations in Human Cancer: Database Reassessment and Prospects for the Next Decade

被引:56
|
作者
Soussi, Thierry [1 ,2 ]
机构
[1] Karolinska Inst, Canc Ctr Karolinska CCK, Dept Oncol Pathol, Stockholm, Sweden
[2] Univ Paris 06, Paris, France
来源
关键词
P53; GENE-MUTATIONS; LARGE T-ANTIGEN; KNOCK-IN MICE; MUTANT P53; WILD-TYPE; SOMATIC MUTATIONS; TRANSCRIPTIONAL ACTIVATION; ARISTOLOCHIC ACID; TERMINAL DOMAIN; STROMAL CELLS;
D O I
10.1016/B978-0-12-386469-7.00005-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TP53 mutations are the most frequent genetic alterations found in human cancer. For more than 20 years, TP53 mutation databases have collected over 30,000 somatic mutations from various types of cancer. Analyses of these mutations have led to many types of studies and have improved our knowledge about the TP53 protein and its function. The recent advances in sequencing methodologies and the various cancer genome sequencing projects will lead to a profound shift in database curation and data management. In this paper, we will review the current status of the TP53 mutation database, its application to various fields of research, and how data quality and curation can be improved. We will also discuss how the genetic data will be stored and handled in the future and the consequences for database management. (C) 2011 Elsevier Inc.
引用
收藏
页码:107 / 139
页数:33
相关论文
共 50 条
  • [1] TP53 Mutations in Human Cancer: Database Reassessment and Prospects for the Next Decade
    Leroy, Bernard
    Anderson, Martha
    Soussi, Thierry
    [J]. HUMAN MUTATION, 2014, 35 (06) : 672 - 688
  • [2] Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations
    Soussi, T
    Kato, S
    Levy, PP
    Ishioka, C
    [J]. HUMAN MUTATION, 2005, 25 (01) : 6 - 17
  • [3] TP53 and mutations in human cancer
    Szymanska, K
    Hainaut, P
    [J]. ACTA BIOCHIMICA POLONICA, 2003, 50 (01) : 231 - 238
  • [4] TP53 mutations in human meningiomas
    Verheijen, FM
    Sprong, M
    Kloosterman, JME
    Blaauw, G
    Thijssen, JHH
    Blankenstein, MA
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (01): : 42 - 48
  • [5] Analysis of TP53 Mutation Status in Human Cancer Cell Lines: A Reassessment
    Leroy, Bernard
    Girard, Luc
    Hollestelle, Antoinette
    Minna, John D.
    Gazdar, Adi F.
    Soussi, Thierry
    [J]. HUMAN MUTATION, 2014, 35 (06) : 756 - 765
  • [6] TP53 mutations in human skin cancers
    Giglia-Mari, G
    Sarasin, A
    [J]. HUMAN MUTATION, 2003, 21 (03) : 217 - 228
  • [7] TP53 Mutations in Breast and Ovarian Cancer
    Silwal-Pandit, Laxmi
    Langerod, Anita
    Borresen-Dale, Anne-Lise
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (01):
  • [8] TP53 mutations in epithelial ovarian cancer
    Zhang, Yu
    Cao, Lan
    Daniel Nguyen
    Lu, Hua
    [J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 (06) : 650 - 663
  • [9] TP53 mutations in head and neck cancer
    Beutner, Dirk
    Klussmann, Jens-Peter
    Guntinas-Lichius, Orlando
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (11): : 1194 - 1194
  • [10] TP53 MUTATIONS ARE IMMUNOGENIC IN EPITHELIAL CANCER
    不详
    [J]. CANCER DISCOVERY, 2019, 9 (04) : 461 - 461